Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study

2018

Abstract not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

2

Citations